Evidence map›Paper›PMID 24560868›Full record

ArticleGastroenterology2014

The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.

Petra Krause, Sonja P Zahner, Gisen Kim, Raziyah B Shaikh, Marcos W Steinberg, Mitchell Kronenberg

Abstract read
In one paragraph

Article in Gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. The Consumption of the Fibrous Fraction ofFoods (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. CD4Frontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Petra KrauseDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California.
Sonja P ZahnerDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California.
Gisen KimDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California.
Raziyah B ShaikhDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California.
Marcos W SteinbergDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California.
Mitchell KronenbergDivision of Developmental Immunology, La Jolla Institute for Allergy & Immunology, La Jolla, California. Electronic address: mitch@liai.org.
La Jolla Institute for Immunology · US

Funding

Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
The role of LIGHT in Colitis PathogenesisR01AI061516 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI KRONENBERG, MITCHELL · 2004 to 2015
$4.5M
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NIAID NIH HHS AI61516NIAID NIH HHS R01 AI061516NIDDK NIH HHS DK46763NIDDK NIH HHS P01 DK046763
6 · The paper itself

Abstract

BACKGROUND &

aimsThe pathogenesis of inflammatory bowel disease (IBD) is associated with a dysregulated mucosal immune response. Expression of the tumor necrosis factor (TNF) superfamily member 14 (TNFSF14, also known as LIGHT [homologous to lymphotoxins, exhibits inducible expression, and competes with HSV glycoprotein D for HVEM, a receptor expressed by T lymphocytes]) on T cells is involved in their activation; transgenic expression of LIGHT on T cells in mice promotes inflammation in multiple organs, including intestine. We investigated the roles for LIGHT in recovery from intestinal inflammation in mice.

methodsWe studied the role of LIGHT in intestinal inflammation using Tnfsf14(-/-) and wild-type mice. Colitis was induced by transfer of CD4(+)CD45RB(high) T cells into Rag1(-/-) or Tnfsf14(-/-)Rag1(-/-) mice, or by administration of dextran sulfate sodium to Tnfsf14(-/-) or wild-type C57BL/6J mice. Mice were weighed, colon tissues were collected and measured, and histology analyses were performed. We measured infiltrating cell populations and expression of cytokines, chemokines, and LIGHT.

resultsAfter administration of dextran sulfate sodium, Tnfsf14(-/-) mice developed more severe colitis than controls, based on their reduced survival, accelerated loss of body weight, and histologic scores. LIGHT protected mice from colitis via the lymphotoxin β receptor and was expressed mainly by myeloid cells in the colon. Colons of Tnfsf14(-/-) mice also had increased accumulation of innate immune cells and higher levels of cytokines than colons from control mice. LIGHT, therefore, appears to regulate inflammation in the colon.

conclusionsTnfsf14(-/-) mice develop more severe colitis than control mice. LIGHT signals through the lymphotoxin β receptor in the colon to regulate the innate immune response and mediate recovery from intestinal inflammation.

Indexed as

AnimalsCD4-Positive T-LymphocytesColitisColonCytokinesDextran SulfateDisease Models, AnimalHomeodomain ProteinsImmunity, InnateInflammation MediatorsIntestinal MucosaLeukocyte Common AntigensLymphotoxin beta ReceptorMiceMice, Inbred C57BLMice, KnockoutCytokinesDextran SulfateHomeodomain ProteinsInflammation MediatorsLeukocyte Common AntigensLtbr protein, mouseLymphotoxin beta ReceptorPTPRC protein, humanRAG-1 proteinTnfsf14 protein, mouseTumor Necrosis Factor Ligand Superfamily Member 14IBDInnate ImmunityMouse ModelUlcerative Colitis

Identifiers

PMID24560868
PMCPMC4035425
OpenAlexW2155866511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.